remdesivir
Remdesivir is a drug used to treat COVID-19, Covid19, SARS-CoV Infection, and other conditions. Remdesivir is being actively studied in 29 studies and prior, has been studied in 23.
Top Sponsors | Top Sites | Top Investigators |
---|---|---|
National Institute of Allergy and Infectious Diseases (NIAID) | Emory Vaccine Center - The Hope Clinic | Abu Taiub Mohammed Mohiuddin Chowdhury |
Gilead Sciences | Jacobi Medical Center | Ahmed Essam |
Capital Medical University | Montefiore Medical Center - Infectious Diseases | Bin Cao |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Recruiting
- Covid19
- End Stage Renal Failure on Dialysis
- Remdesivir
- Budapest, HungarySemmelweis University - Department of Internal Medicine and Onco
2022-03-03
Mar 3, 2022A
Comparison of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients
Recruiting
- Covid19
- Remdesivir
- Lopinavir/ Ritonavir and Remdesivir combination
- Banī Suwayf, EgyptBeni-suef University
2021-03-15
Mar 15, 2021B
Completed
- Duration of Hospitalization
- Clinical Manifestation of COVID-19
- Remdesivir
- Surabaya, East Java, IndonesiaGotong Royong Surabaya Hospital
2022-01-23
Jan 23, 2022T
Completed
- COVID
- Remdesivir
- Standard of care treatment
- Tanta, EgyptTanta university hospital, Assuit University, Ainshams Universit
2021-07-29
Jul 29, 2021M
Completed
- Ebola
- HIV/AIDS
- Remdesivir
- Kampala, UgandaInfectious Diseases Institute
2021-08-19
Aug 19, 2021T
Recruiting
- Covid19
- Interferon beta-1b
- Remdesivir
- Hong Kong, Hong KongQueen Mary Hospital
2020-12-09
Dec 9, 2020A
Completed
- Covid19
- Remdesivir
- +2 more
- Cairo, Non-US, EgyptFaculty of Medicine Ain Shams University Research Institute- Cli
2021-04-17
Apr 17, 2021D
Completed
- Covid19
- Remdesivir
- Standard of Care
- Dhaka, BangladeshCombined Military Hospital
2021-08-09
Aug 9, 2021M
Recruiting
- Pneumonia, Viral
- Remdesivir
- Mansoura, Dakahliya, EgyptMansoura University Hospital
2021-01-27
Jan 27, 2021A
Completed
- COVID-19
- Remdesivir
- Paris, FranceHôpital Cochin
2021-04-16
Apr 16, 2021B
N
Recruiting
- Covid19
- Remdesivir
- Birgunj, Nepal
- +3 more
2020-12-15
Dec 15, 2020M
Completed
- Covid19
- Covid-19 ARDS
- Remdesivir
- Tocilizumab
- Chittagong, Bangladesh
- +3 more
2021-03-31
Mar 31, 2021L
Recruiting
- SARS-CoV Infection
- Remdesivir
- Lahore, Punjab, PakistanMuhammad Irfan Malik
2020-09-24
Sep 24, 2020C
Terminated
- COVID-19
- +2 more
- Remdesivir
- Remdesivir placebo
- Beijing, Beijing, ChinaBin Cao
2020-04-13
Apr 13, 2020K
O
Recruiting
- Covid19
- Pneumonia
- Remdesivir
- +4 more
- Banī Suwayf, EgyptBeni-suef University
2021-03-15
Mar 15, 2021C
Suspended
- COVID-19
- SARS-CoV-2
- Remdesivir
- Remdesivir placebo
- Wuhan, Hubei, ChinaJin Yin-tan hospital
2020-04-13
Apr 13, 2020V
U
No longer available
- Coronavirus Disease 2019
- Remdesivir
- San Diego, California
- +21 more
2022-02-15
Feb 15, 2022C
Recruiting
- Covid19
- Remdesivir
- Helsinki, FinlandUniversity of Helsinki
2021-10-12
Oct 12, 2021T
Not yet recruiting
- Covid19
- Remdesivir
- +3 more
- Kingston, JamaicaUniveristy of the West Indies
2021-05-10
May 10, 2021N
Active, not recruiting
- COVID-19
- Remdesivir
- Los Angeles, California
- +18 more
2022-02-17
Feb 17, 2022A
Not yet recruiting
- Covid19
- Baricitinib Oral Tablet [Olumiant]
- +2 more
- Ancona, Italy
- +20 more
2021-04-03
Apr 3, 2021M
Recruiting
- Covid19
- Covid-19 ARDS
- Remdesivir
- +2 more
- Dinajpur, BangladeshM. Abdur Rahim Medical College Hospital
2020-12-31
Dec 31, 2020